Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
The University of Bath Researchers Develop New Saliva Test to Detect Synthetic Drug
A simple saliva test has been developed by the researchers at the University of Bath to detect if someone has recently taken the street drug ‘spice’. The substance known as ‘spice’, is usually a mixture of dried and shredded plant material, sprayed with various synthetic chemicals meant to mimic the main component of cannabis....
Mirum Pharmaceuticals Launch New Drug for Treatment of Alagille Syndrome
Mirum Pharmaceuticals has launched a novel drug Maralixibat, for the treatment of pruritus associated with Alagille syndrome (ALGS) in patients one year of age and older. ALGS is a rare genetic disorder within which digestive juice ducts are abnormally slim, unshapely and reduced in a range that ends up in digestive juice within the liver and ultimately progressive disease....
Eli Lilly Launch New Drug to Treat Acute Migraine in Adults
A new oral medication, REYVOW™ (lasmiditan) has been launched by Eli Lilly and Company for the treatment of acute migraine, with or without aura, in adults. The drug, REYVOW is delivered orally via a tablet and is the first serotonin receptor agonist. It binds to (5-HT) 1F receptor with high affinity....
New Oral Inhibitor Launched to Treat Patients with Histiocytic Neoplasms
A new oral inhibitor, cobimetinib (Cotellic) has been launched by the Memorial Sloan Kettering Cancer Center (MSK) for the treatment of adult patients with histolytic neoplasms (HN) (Erdheim-Chester Disease, Rosai-Dorfman, Langerhans Histiocytosis)....
Janssen Pharma’s Niraparib Treats Patients with Prostate Cancer
A new orally-administered poly ADP-ribose polymerase (PARP) inhibitor, Niraparib has been launched by the Janssen Pharmaceutical Companies of Johnson & Johnson....
UC Santa Cruz Researchers Develop Novel Nanoprobes
A new ultrasensitive nanoscale optical probe has been developed by the researchers at UC Santa Cruz that can monitor the bioelectric activity of neurons and other excitable cells....
Boehringer Ingelheim Launches Breakthrough Medication for Treatment of ILDs
A new medication, Ofev® (nintedanib) has been launched by Boehringer Ingelheim for the treatment of patients with chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype....
Roche's New Lymphoma Medicine to Treat Lupus Nephritis
Genentech, a member of the Roche Group announced that a new lymphoma medicine under the name Gazyva® (obinutuzumab) has been launched to treat adults with lupus nephritis....
Breakthrough Drug Launched to Treat Desmoid Tumors in Adult Patients
SpringWorks Therapeutics has launched its experimental drug, nirogacestat for the treatment of adult patients with rare and progressive cancer known as desmoid tumors....
Janssen Launches RSV Vaccine to Treat Older Patients
An investigational prophylactic vaccine has been launched by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease....
